Insmed Inc (INSM)
24.80
-0.12
(-0.48%)
USD |
NASDAQ |
Apr 26, 16:00
24.80
0.00 (0.00%)
After-Hours: 20:00
Insmed Cash from Investing (Quarterly): 1.803M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.803M |
| September 30, 2023 | 7.147M |
| June 30, 2023 | -274.16M |
| March 31, 2023 | 41.60M |
| December 31, 2022 | 20.31M |
| September 30, 2022 | 49.42M |
| June 30, 2022 | -2.904M |
| March 31, 2022 | -101.41M |
| December 31, 2021 | -51.22M |
| September 30, 2021 | -8.401M |
| June 30, 2021 | -3.485M |
| March 31, 2021 | -1.181M |
| December 31, 2020 | -1.515M |
| September 30, 2020 | -0.747M |
| June 30, 2020 | -1.881M |
| March 31, 2020 | -2.679M |
| December 31, 2019 | -13.04M |
| September 30, 2019 | -14.59M |
| June 30, 2019 | -10.61M |
| March 31, 2019 | -4.028M |
| December 31, 2018 | -4.751M |
| September 30, 2018 | -1.851M |
| June 30, 2018 | -2.847M |
| March 31, 2018 | -5.365M |
| December 31, 2017 | -1.70M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.447M |
| June 30, 2017 | -0.437M |
| March 31, 2017 | -0.417M |
| December 31, 2016 | -0.772M |
| September 30, 2016 | -1.30M |
| June 30, 2016 | -1.54M |
| March 31, 2016 | -0.588M |
| December 31, 2015 | -0.407M |
| September 30, 2015 | -0.853M |
| June 30, 2015 | -0.93M |
| March 31, 2015 | -1.264M |
| December 31, 2014 | -1.527M |
| September 30, 2014 | -2.919M |
| June 30, 2014 | -0.564M |
| March 31, 2014 | -0.331M |
| December 31, 2013 | -0.113M |
| September 30, 2013 | 1.933M |
| June 30, 2013 | -0.33M |
| March 31, 2013 | -0.161M |
| December 31, 2012 | 44.59M |
| September 30, 2012 | -0.028M |
| June 30, 2012 | 4.12M |
| March 31, 2012 | 12.84M |
| December 31, 2011 | 10.48M |
| September 30, 2011 | 8.64M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-274.16M
Minimum
Jun 2023
49.42M
Maximum
Sep 2022
-19.34M
Average
-2.679M
Median
Mar 2020
Cash from Investing (Quarterly) Benchmarks
| NeuroMetrix Inc | 0.098M |
| Intra-Cellular Therapies Inc | 47.42M |
| Rhythm Pharmaceuticals Inc | 22.64M |
| Amylyx Pharmaceuticals Inc | 20.92M |
| AN2 Therapeutics Inc | 0.42M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -130.82M |
| Cash from Financing (Quarterly) | 123.26M |
| Free Cash Flow | -549.54M |
| Free Cash Flow Per Share (Quarterly) | -0.918 |
| Free Cash Flow to Equity (Quarterly) | -140.77M |
| Free Cash Flow to Firm (Quarterly) | -112.08M |
| Free Cash Flow Yield | -15.78% |